Metastatic neuroendocrine pancreatic tumor – Case report

Autor: Radu, EC, Saizu, AI, Grigorescu, RR, Croitoru, AE, Gheorghe, C

Publikováno v: Journal of Medicine and Life

Rationale.Pancreatic neuroendocrine tumors (NETs) are rare neoplasms that develop from the endocrine tissues of the pancreas. They have a better overall prognosis than pancreatic adenocarcinoma. However, all commonly used classification systems refle

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::8eab18fbd3e16bf48215f18f89e74858
http://europepmc.org/articles/PMC5909947

Dynamics of RAS Mutations in Liquid Biopsies in Metastatic Colorectal Cancer Patients-Case Series and Literature Review.

Autor: Popescu I; Faculty of Medicine, Titu Maiorescu University, 031593 Bucharest, Romania., Croitoru VM; Faculty of Medicine, Titu Maiorescu University, 031593 Bucharest, Romania.; Department of Oncology, Fundeni Clinical Institute, 022328 Bucharest, Romania., Croitoru-Cazacu IM; Department of Oncology, Fundeni Clinical Institute, 022328 Bucharest, Romania.; Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania., Dudau AM; Faculty of Medicine, Titu Maiorescu University, 031593 Bucharest, Romania.; Department of Oncology, Fundeni Clinical Institute, 022328 Bucharest, Romania., Herlea V; Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.; Department of Pathology, Fundeni Clinical Institute, 022328 Bucharest, Romania., Dima SO; Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.; Center of Excellence in Translational Medicine, Fundeni Clinical Institute, 022328 Bucharest, Romania., Croitoru AE; Department of Oncology, Fundeni Clinical Institute, 022328 Bucharest, Romania.

Publikováno v: Journal of personalized medicine [J Pers Med] 2024 Jul 15; Vol. 14 (7). Date of Electronic Publication: 2024 Jul 15.

Real-Life Results of Palliative Chemotherapy in Metastatic Pancreatic Ductal Adenocarcinoma.

Autor: Varzaru B; Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.; Gastroenterology Department, Sanador Clinical Hospital, 010991 Bucharest, Romania., Iacob RA; Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.; Digestive Diseases and Liver Transplantation Center, Fundeni Clinical Institute, 022238 Bucharest, Romania., Croitoru AE; Oncology Department, Fundeni Clinical Institute, 022238 Bucharest, Romania.; Faculty of Medicine, Titu Maiorescu University, 040441 Bucharest, Romania., Iacob SM; Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.; Digestive Diseases and Liver Transplantation Center, Fundeni Clinical Institute, 022238 Bucharest, Romania., Radu CE; Saint Mary Clinical Hospital, 011172 Bucharest, Romania., Dumitrescu SM; Oncology Department, Fundeni Clinical Institute, 022238 Bucharest, Romania., Gheorghe C; Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.; Digestive Diseases and Liver Transplantation Center, Fundeni Clinical Institute, 022238 Bucharest, Romania.

Publikováno v: Cancers [Cancers (Basel)] 2023 Jul 05; Vol. 15 (13). Date of Electronic Publication: 2023 Jul 05.

Bevacizumab Treatment for Metastatic Colorectal Cancer in Real-World Clinical Practice.

Autor: Dinu IM; Department of Oncology, Fundeni Clinical Institute, 022328 Bucharest, Romania., Mihăilă M; Department of Internal Medicine, Fundeni Clinical Institute, 022328 Bucharest, Romania., Diculescu MM; Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.; Department of Gastroenterology, Fundeni Clinical Institute, 022328 Bucharest, Romania., Croitoru VM; Department of Oncology, Fundeni Clinical Institute, 022328 Bucharest, Romania., Turcu-Stiolica A; Department of Pharmacoeconomics, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania., Bogdan D; Department of Oncology, Fundeni Clinical Institute, 022328 Bucharest, Romania., Miron MI; Department of Oncology, Fundeni Clinical Institute, 022328 Bucharest, Romania., Lungulescu CV; Department of Oncology, University of Medicine and Pharmacy Craiova, 200349 Craiova, Romania.; Department of Oncology, County Clinical Emergency Hospital, 200642 Craiova, Romania., Alexandrescu ST; Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.; Department of Surgery, Fundeni Clinical Institute, 022328 Bucharest, Romania., Dumitrașcu T; Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.; Department of Surgery, Fundeni Clinical Institute, 022328 Bucharest, Romania., Buică F; Department of Oncology, Fundeni Clinical Institute, 022328 Bucharest, Romania.; Faculty of Medicine, Titu Maiorescu University, 031593 Bucharest, Romania., Luca IN; Department of Oncology, Fundeni Clinical Institute, 022328 Bucharest, Romania., Lungulescu C; Department of Oncology, County Clinical Emergency Hospital, 200642 Craiova, Romania., Negulescu MC; Department of Oncology, Fundeni Clinical Institute, 022328 Bucharest, Romania., Gramaticu IM; Department of Oncology, Fundeni Clinical Institute, 022328 Bucharest, Romania., Cazacu IM; Department of Oncology, Fundeni Clinical Institute, 022328 Bucharest, Romania.; Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania., Croitoru AE; Department of Oncology, Fundeni Clinical Institute, 022328 Bucharest, Romania.; Department of Surgery, Fundeni Clinical Institute, 022328 Bucharest, Romania.

Publikováno v: Medicina (Kaunas, Lithuania) [Medicina (Kaunas)] 2023 Feb 13; Vol. 59 (2). Date of Electronic Publication: 2023 Feb 13.

Establishment of CORONET, COVID-19 Risk in Oncology Evaluation Tool, to Identify Patients With Cancer at Low Versus High Risk of Severe Complications of COVID-19 Disease On Presentation to Hospital.

Autor: Lee RJ; The Christie NHS Foundation Trust, Manchester, United Kingdom.; The University of Manchester, Manchester, United Kingdom., Wysocki O; The University of Manchester, Manchester, United Kingdom.; Cancer Research UK Manchester Institute Cancer Biomarker Center, The University of Manchester, Alderley Park, United Kingdom., Zhou C; Cancer Research UK Manchester Institute Cancer Biomarker Center, The University of Manchester, Alderley Park, United Kingdom., Shotton R; The Christie NHS Foundation Trust, Manchester, United Kingdom., Tivey A; The Christie NHS Foundation Trust, Manchester, United Kingdom.; The University of Manchester, Manchester, United Kingdom., Lever L; The University of Manchester, Manchester, United Kingdom., Woodcock J; The University of Manchester, Manchester, United Kingdom., Albiges L; Department of Medical Oncology, Gustave Roussy, Villejuif, France., Angelakas A; The Christie NHS Foundation Trust, Manchester, United Kingdom., Arnold D; Department of Oncology, Haematology and Palliative Care, Asklepios Klinik Altona, Hamburg, Germany., Aung T; Weston Park Cancer Center, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Banfill K; The Christie NHS Foundation Trust, Manchester, United Kingdom.; The University of Manchester, Manchester, United Kingdom., Baxter M; Division of Molecular and Clinical Medicine, Ninewells School of Medicine, University of Dundee, Dundee, United Kingdom., Barlesi F; Department of Medical Oncology, Gustave Roussy, Villejuif, France.; Aix Marseille University, CNRS, INSERM, CRCM, Marseille, France., Bayle A; Drug Development Department (DITEP) Gustave Roussy-Cancer Campus, Villejuif, France.; Oncostat U1018, Inserm, Paris-Saclay University, Labeled Ligue Contre le Cancer, Villejuif, France., Besse B; Drug Development Department (DITEP) Gustave Roussy-Cancer Campus, Villejuif, France., Bhogal T; The Clatterbridge Cancer Center NHS Foundation Trust, Liverpool, United Kingdom., Boyce H; Weston Park Cancer Center, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Britton F; The Christie NHS Foundation Trust, Manchester, United Kingdom., Calles A; Hospital General Universitario Gregorio Marañón, Madrid, Spain., Castelo-Branco L; ESMO-CoCARE Steering Committee, European Society for Medical Oncology, Lugano, Switzerland.; NOVA National School of Public Health, Lisboa, Portugal.; Department of Medical Oncology, University Hospital Center of Algarve, Faro, Portugal., Copson E; Cancer Sciences Academic Unit, Southampton General Hospital, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom., Croitoru AE; Medical Oncology Department, Fundeni Clinical Institute, Bucureşti, Romania., Dani SS; Lahey Hospital and Medical Center, Burlington, MA., Dickens E; Oncology Department, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom., Eastlake L; University Hospitals Plymouth NHS Trust, Crownhill, Plymouth, Devon, United Kingdom., Fitzpatrick P; Cancer Research UK Manchester Institute Cancer Biomarker Center, The University of Manchester, Alderley Park, United Kingdom., Foulon S; Oncostat U1018, Inserm, Paris-Saclay University, Labeled Ligue Contre le Cancer, Villejuif, France.; Biostatistics and Epidemiology Office, Gustave Roussy, University Paris-Saclay, Villejuif, France., Frederiksen H; Department of Haematology, Odense University Hospital, Odense, Denmark., Frost H; Cancer Research UK Manchester Institute Cancer Biomarker Center, The University of Manchester, Alderley Park, United Kingdom., Ganatra S; Lahey Hospital and Medical Center, Burlington, MA., Gennatas S; The Royal Marsden NHS Foundation Trust, London, United Kingdom., Glenthøj A; Department of Haematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark., Gomes F; The Christie NHS Foundation Trust, Manchester, United Kingdom., Graham DM; The Christie NHS Foundation Trust, Manchester, United Kingdom.; The University of Manchester, Manchester, United Kingdom., Hague C; The Christie NHS Foundation Trust, Manchester, United Kingdom., Harrington K; The Royal Marsden NHS Foundation Trust, London, United Kingdom.; The Institute of Cancer Research NIHR Biomedical Research Center, London, United Kingdom., Harrison M; Ninewells Hospital and Medical School, Dundee, United Kingdom., Horsley L; The Christie NHS Foundation Trust, Manchester, United Kingdom., Hoskins R; Research IT, University of Manchester, Manchester, United Kingdom., Huddar P; Royal Preston Hospital, Lancashire Teaching Hospitals, Fulwood, Preston, United Kingdom., Hudson Z; Bristol Haematology and Oncology Center, University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom., Jakobsen LH; Department of Haematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark., Joharatnam-Hogan N; University College London Hospitals NHS Foundation Trust, London, United Kingdom.; MRC Clinical Trials Unit, University College London, London, United Kingdom., Khan S; Weston Park Cancer Center, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Khan UT; The Clatterbridge Cancer Center NHS Foundation Trust, Liverpool, United Kingdom.; The University of Liverpool, Liverpool, United Kingdom., Khan K; University College London Hospitals NHS Foundation Trust, London, United Kingdom., Massard C; Drug Development Department (DITEP) Gustave Roussy-Cancer Campus, Villejuif, France., Maynard A; Weston Park Cancer Center, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., McKenzie H; Cancer Sciences Academic Unit, Southampton General Hospital, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom., Michielin O; Department of Oncology, Melanoma Clinic, Swiss Institute of Bioinformatics, Quartier Sorge-Batiment Amphipole, Lausanne, Switzerland., Mosenthal AC; Lahey Hospital and Medical Center, Burlington, MA., Obispo B; Hospital Universitario Infanta Leonor, Madrid, Spain., Patel R; Lahey Hospital and Medical Center, Burlington, MA., Pentheroudakis G; ESMO-CoCARE Steering Committee, European Society for Medical Oncology, Lugano, Switzerland., Peters S; ESMO-CoCARE Steering Committee, European Society for Medical Oncology, Lugano, Switzerland.; Medical Oncology, Center Hospitalier Universitaire Vaudois, Lausanne, Switzerland., Rieger-Christ K; Lahey Hospital and Medical Center, Burlington, MA., Robinson T; Bristol Haematology and Oncology Center, University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom.; Population Health Sciences, University of Bristol, Oakfield House, Oakfield Grove, Bristol, United Kingdom., Rogado J; Hospital Universitario Infanta Leonor, Madrid, Spain., Romano E; Department of Oncology, Institut Curie, PSL Research University, Paris, France., Rowe M; Sunrise Center, Royal Cornwall Hospitals NHS Trust, Truro, Cornwall, United Kingdom., Sekacheva M; World-Class Research Center Digital Biodesign and Personalized Healthcare, Sechenov First Moscow State Medical University, Moscow, Russia., Sheehan R; Weston Park Cancer Center, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Stevenson J; Cancer Research UK Manchester Institute Cancer Biomarker Center, The University of Manchester, Alderley Park, United Kingdom., Stockdale A; Tropical and Infectious Diseases Unit, Royal Liverpool University Hospital, Liverpool, United Kingdom., Thomas A; Oncology Department, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom.; Leicester Cancer Research Centre, The University of Leicester, Leicester, United Kingdom., Turtle L; Tropical and Infectious Diseases Unit, Royal Liverpool University Hospital, Liverpool, United Kingdom., Viñal D; Department of Medical Oncology, Hospital Universitario La Paz, Madrid, Spain., Weaver J; The Christie NHS Foundation Trust, Manchester, United Kingdom.; The University of Manchester, Manchester, United Kingdom., Williams S; Weston Park Cancer Center, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Wilson C; Weston Park Cancer Center, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Palmieri C; The Clatterbridge Cancer Center NHS Foundation Trust, Liverpool, United Kingdom.; The University of Liverpool, Liverpool, United Kingdom., Landers D; Cancer Research UK Manchester Institute Cancer Biomarker Center, The University of Manchester, Alderley Park, United Kingdom., Cooksley T; The Christie NHS Foundation Trust, Manchester, United Kingdom., Dive C; Cancer Research UK Manchester Institute Cancer Biomarker Center, The University of Manchester, Alderley Park, United Kingdom., Freitas A; The University of Manchester, Manchester, United Kingdom.; Cancer Research UK Manchester Institute Cancer Biomarker Center, The University of Manchester, Alderley Park, United Kingdom.; Department of Medical Oncology, Gustave Roussy, Villejuif, France., Armstrong AC; The Christie NHS Foundation Trust, Manchester, United Kingdom.; The University of Manchester, Manchester, United Kingdom.

Publikováno v: JCO clinical cancer informatics [JCO Clin Cancer Inform] 2022 May; Vol. 6, pp. e2100177.